Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$99,044,749
+$11,156,171 QoQ
Shares Held
393,597
-2.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
#257
of 4,153 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$226,476
PutShares
900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank Pictet & Cie (Europe) AG holds $216,179,897 across 9 Drug Manufacturers - General names. ABBV ranks #1 (45.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
393,597 | $99,044,749 | |
| 2 | LLY |
ELI LILLY & Co
|
44,977 | $53,946,767 | |
| 3 | MRK |
Merck & Co., Inc.
|
232,596 | $29,888,586 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
140,228 | $17,716,405 | |
| 5 | PFE |
Pfizer Inc
|
320,378 | $7,714,702 | |
| 6 | AZN |
Astrazeneca PLC
|
22,759 | $4,315,561 | |
| 7 | JNJ |
Johnson & Johnson
|
8,628 | $2,191,253 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,000 | $691,440 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $99,044,749 | 393,597 | Shares | Sole | 2026-07-24 | |
| 2026-06-30 | $226,476 | 900 | Put | Sole | 2026-07-24 | |
| 2026-03-31 | $87,888,578 | 404,104 | Shares | Sole | 2026-04-14 | |
| 2026-03-31 | $326,235 | 1,500 | Put | Sole | 2026-04-14 | |
| 2025-12-31 | $342,735 | 1,500 | Put | Sole | 2026-01-16 | |
| 2025-12-31 | $96,194,975 | 421,003 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $138,924 | 600 | Put | Sole | 2025-10-21 | |
| 2025-09-30 | $89,634,227 | 387,122 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $50,989,999 | 274,701 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $59,596,078 | 284,441 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $36,519,304 | 205,511 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $40,793,641 | 206,571 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $33,717,573 | 196,581 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $33,889,720 | 186,105 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $21,689,911 | 139,962 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $20,206,871 | 135,562 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $11,929,398 | 88,543 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $13,805,266 | 86,624 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $14,148,632 | 87,548 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,719,230 | 12,810 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $482,454 | 3,150 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $523,615 | 3,230 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $437,342 | 3,230 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $348,420 | 3,230 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $363,827 | 3,230 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $349,550 | 3,230 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||